GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype

NCT01384383 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: GS-5885
DRUG: GS-9451
DRUG: RBV
DRUG: PEG

Sponsor

Gilead Sciences